Screened 2026-07-19 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Veris Residential, Inc. holds its Accumulation at $18.99. Consolidating, no directional conviction, held for 63 days.
As held on the ledger · 2026-07-19
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 63 days
Price at the screen
$18.99
Valuation
26.01 trailing · -67.82 forward price to earnings
Values screen
FAIL
Beta
1.07
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
70.28%
Below 33%
Interest-bearing debt is 70.3% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.48%
Below 33%
Cash held in interest-bearing accounts and securities is 0.5% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-07-19 screen. The gold marker is the market price at the same screen. A 0.1% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus Buy. The average target sits +0% from the screen price.
Reading the gap · Our model and the Street both land near today's price: fairly valued, with no strong edge either way.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-07-19 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Landlord weighed down by debt and flat rents
Picture an apartment owner trying to keep the lights on while juggling bigger loans than the rents coming in. Veris shows revenue shrinking 2 percent, a forward earnings multiple deep in negative territory at minus 67.8 times, and return on equity stuck at just 6 percent. The market consensus still calls it a buy at a 19 dollar target, yet those numbers tell a different story.
The ethical screen blocks the name outright because of the debt ratio. No amount of analyst optimism or the slim fair value match at 19 dollars against the current 18.99 price changes that verdict. Profit margins may sit at 25 percent, but the combination of declining top line and heavy borrowing leaves little room for comfort.
Risks centre on the same leverage that already fails the screen, plus the chance that revenue weakness turns into deeper losses in a higher rate world. The thin margin of safety offers no cushion if conditions worsen. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VRE trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-16Accumulation$18.99-0.1%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (4 analysts) rates it buy, with a mean price target of $20.
2026-07-18Accumulation$19.00+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (4 analysts) rates it buy, with a mean price target of $20.
2026-07-03Accumulation$19.00+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Accumulation$19.00Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
